D-497-2013 Class III Terminated
FDA drug recall D-497-2013 was initiated by Teva Pharmaceuticals USA, Inc. on Mar 14, 2013 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing The recall status is terminated (terminated Jan 15, 2014). Affected quantity: 120,049 blister packs.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 5, 2013
- Initiation Date
- Mar 14, 2013
- Termination Date
- Jan 15, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 120,049 blister packs
Product description
Camrese(TM) (Levonorgestrel/Ethinyl Estradiol Tablets), 0.15 mg/0.03 mg and Ethinyl Estradiol 0.01 Tablets, 2 Extended-Cycle Tablet Dispensers (NDC 0093-3134-82) and 1 Extended-Cycle Tablet Dispenser NDC 0093-3134-91), 91 Tablets Each, Rx only, TEVA Womens Health Inc., Subsidiary of TEVA Pharmaceuticals, Inc., Sellersville, PA
Reason for recall
Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing
Distribution pattern
Nationwide
Code information
NDC 0555-3134-82 and 0093-3134-91 -- lot numbers 33802566A, exp 3/2013; 33802967A, exp 8/2013; 33803529A, exp 10/2013; and 33803609A, exp 11/2013.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-497-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026